Point-of-care and bioprocessing diagnostics for critical care and biomanufacturing
Nova Biomedical operates a medical-device portfolio spanning clinical diagnostics (blood gas and glucose analyzers), biotech instrumentation, and veterinary diagnostics, serving over 100 countries. The company is actively replacing legacy manufacturing equipment and launching next-generation product lines (osmometers, blood gas analyzers)—while simultaneously managing a platform transformation initiative and scaling sales territory coverage, indicating a simultaneous push toward modernized operations and market growth. Hiring velocity is accelerating with manufacturing and sales roles leading the intake, typical of companies balancing operational efficiency upgrades with commercial expansion.
Nova Biomedical is a privately held, U.S.-based manufacturer of in vitro diagnostic (IVD) and biotech instruments founded in 1976 and now operating at 1,001–5,000 employees. The company merged with Advanced Instruments to consolidate expertise across clinical diagnostics, bioprocessing, and animal health. Core products include blood-gas and glucose analyzers for hospital critical-care settings, real-time cell-culture monitoring systems for biomanufacturing, and veterinary diagnostic devices. The business reinvests significantly into R&D and operates across over 100 countries, positioning itself as the largest privately held IVD company in the United States. Current operational priorities include modernizing manufacturing infrastructure, growing blood-gas market share, and advancing unreleased product pipelines.
Core systems include .NET Framework, C#, Visual Studio, SAP, AVEVA Wonderware (industrial controls), Excel, and Windows-based infrastructure. Specialized design uses Mastercam for manufacturing tooling.
Active projects include next-generation osmometers, expanded blood-gas analyzer footprint, new product installations, and bioprocessing device advancements. The company is also replacing legacy manufacturing equipment to improve quality and efficiency.
Other companies in the same industry, closest in size